Department of Medicine 5 – Haematology and Oncology

Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage (2019) Sprügel M, Kuramatsu J, Gerner ST, Sembill J, Madzar D, Reindl C, Bobinger T, et al. Journal article Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope registry and from the literature (2019) Stemler J, Salmanton-Garcia J, Seidel D, Alexander BD, Bertz H, Hoenigl M, Herbrecht R, et al. Journal article The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease (2019) Srinagesh H, Ozbek U, Kapoor U, Ayuk FA, Aziz MD, Ben-David K, Choe HK, et al. Conference contribution High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response (2019) Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, et al. Conference contribution beta(2)-m - a Trigger for NLRP3 Inflammasome Activation within Macrophages Promoting Multiple Myeloma Cell Proliferation (2019) Hofbauer D, Mougiakakos D, Büttner-Herold M, Neumann F, Nolting J, Bisht S, Zeiser R, et al. Conference contribution Mechanistic Characterization of Tafasitamab-Mediated Antibody-Dependent Cellular Phagocytosis Alone or in Combination with Lenalidomide (2019) Mougiakakos D, Völkl S, Bach C, Stoll A, Bitterer K, Beier F, Endell J, et al. Conference contribution Microenvironmental Triggers Induce a Chemoresistant, Differentiated Subset of S100A8/A9(high) AML Cells Via the Jak/STAT3 Signaling Axis (2019) Böttcher M, Panagiotidis K, Mentz K, Völkl S, Bruns H, Slany R, Mackensen A, Mougiakakos D Conference contribution Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia (2019) Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Sauer T, et al. Journal article The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective (2019) Mougiakakos D Journal article, Review article